Novel indol-3-yl-thiosemicarbazone derivatives: Obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies

被引:20
|
作者
da Silva, Paula Roberta [1 ]
de Oliveira, Jamerson Ferreira [1 ]
da Silva, Anekecia Lauro [2 ]
Queiroz, Camila Marques [3 ]
Sampaio Feitosa, Ana Paula [3 ]
Araujo Duarte, Denise Maria Figueiredo [1 ]
da Silva, Aline Caroline [4 ]
Brelaz de Castro, Maria Carolina Accioly [4 ,5 ]
Alves Pereira, Valeria Rego [4 ]
Ferreira da Silva, Rosali Maria [6 ]
Alves, Luiz Carlos [3 ]
Brayner dos Santos, Fabio Andre [3 ]
Alves de Lima, Maria do Carmo [1 ]
机构
[1] Univ Fed Pernambuco UFPE, Dept Antibiot, BR-50670901 Recife, PE, Brazil
[2] Univ Fed Vale Sao Francisco UNIVASF, Dept Med, BR-48607190 Paulo Afonso, BA, Brazil
[3] Fundacao Oswaldo Cruz IAM FIOCRUZ, Dept Parasitol, Inst Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil
[4] Fundacao Oswaldo Cruz IAM FIOCRUZ, Dept Imunol, Inst Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil
[5] Univ Fed Pernambuco UFPE, Nucleo Enfermagem, BR-55608680 Vitoria De Santo Antao, PE, Brazil
[6] Univ Fed Pernambuco UFPE, Dept Ciencias Farmaceut DCFAR, BR-50670901 Recife, PE, Brazil
关键词
Leishmania infantum; Leishmania amazonensis; Thiosemicarbazone; Indole derivatives; Ultrastructural studies; ANTILEISHMANIAL ACTIVITY; ARYL THIOSEMICARBAZONES; TRYPANOSOMA-CRUZI; CELL-DEATH; VISCERAL LEISHMANIASIS; CYTOTOXIC EVALUATION; INFANTUM; POTENT; INHIBITION; DIAGNOSIS;
D O I
10.1016/j.cbi.2019.108899
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parasitic diseases still represent serious public health problems, since the high and steady emergence of resistant strains is evident. Because parasitic infections are distributed predominantly in developing countries, less toxic, more efficient, safer and more accessible drugs have become desirable in the treatment of the infected population. This is the case of leishmaniasis, an infectious disease caused by a protozoan of the genus Leishmania sp., responsible for triggering pathological processes from the simplest to the most severe forms leading to high rates of morbidity and mortality throughout the world. In the search for new leishmanicidal drugs, the thiosemi-carbazones and the indole fragments have been identified as promising structures for leishmanicidal activity. The present study proposes the synthesis and structural characterization of new indole-thiosemicarbazone derivatives (2a-j), in addition to performing in vitro evaluations through cytotoxicity assays using macrophages (J774) activity against forms of Leishmania infantum and Leishmania amazonensis promastigote as well as ultrastructural analyzes in promastigotes of L. infantum. Results show that the indole-thiosemicarbazone derivatives were obtained with yield values varying from 32.09 to 94.64%. In the evaluation of cytotoxicity, the indol-ethiosemicarbazone compounds presented CC50 values between 53.23 and 357.97 mu M. Concerning the evaluation against L. amazonensis promastigote forms, IC50 values ranged between 12.31 and > 481.52 mu M, while the activity against L. infantum promastigotes obtained IC50 values between 4.36 and 23.35 mu M. The compounds 2d and 2i tested against L. infantum were the most promising in the series, as they showed the lowest IC50 values: 5.60 and 4.36 respectively. The parasites treated with the compounds 2d and 2i showed several structural alterations, such as shrinkage of the cell body, shortening and loss of the flagellum, intense mitochondrial swelling and vacuolization of the cytoplasm leading the parasite to cellular unviability. Therefore, the indole-thiosemicarbazone compounds are promising because they yield considerable synthesis, have low cytotoxicity to mammalian cells and act as leishmanicidal agents.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives
    Hoemann, MZ
    Xie, RL
    Rossi, RF
    Meyer, S
    Sidhu, A
    Cuny, GD
    Hauske, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (02) : 129 - 132
  • [22] Patent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives
    Hoemann, MZ
    Kumaravel, G
    Xie, RL
    Rossi, RF
    Meyer, S
    Sidhu, A
    Cuny, GD
    Hauske, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (23) : 2675 - 2678
  • [23] Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives
    Zhang, Datong
    Wang, Guangtian
    Zhao, Guilong
    Xu, Weiren
    Huo, Lingyan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (12) : 5868 - 5877
  • [24] Novel 1,3,4-Thiadiazole-2-yl-pyrimidine Derivatives In Vitro and the Etymology of Antifungal Activity
    Andrews, B.
    Sudarsan, S.
    Durairaj, A. Leo Michael
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2024, 60 (SUPPL1) : S22 - S27
  • [25] Synthesis, characterization, and SAR studies of new (1H-indol-3-yl)alkyl-3-(1H-indol-3-yl)propanamide derivatives as possible antimicrobial and antitubercular agents
    Ranjith Pakkath Karuvalam
    Rajeesh Pakkath
    Karickal Raman Haridas
    Rathnasamy Rishikesan
    Nalilu Suchetha Kumari
    Medicinal Chemistry Research, 2013, 22 : 4437 - 4454
  • [26] Synthesis, characterization, and SAR studies of new (1H-indol-3-yl)alkyl-3-(1H-indol-3-yl)propanamide derivatives as possible antimicrobial and antitubercular agents
    Karuvalam, Ranjith Pakkath
    Pakkath, Rajeesh
    Haridas, Karickal Raman
    Rishikesan, Rathnasamy
    Kumari, Nalilu Suchetha
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (09) : 4437 - 4454
  • [27] Synthesis and evaluation of in vitro anticancer activity of novel solasodine derivatives
    Zha, Xiao Ming
    Zhang, Fei Ran
    Shan, Jia Qi
    Zhang, Yi Hua
    Liu, Jun O.
    Sun, Hong Bin
    CHINESE CHEMICAL LETTERS, 2010, 21 (09) : 1087 - 1090
  • [28] Synthesis and evaluation of in vitro anticancer activity of novel solasodine derivatives
    Xiao Ming Zha~(a
    ChineseChemicalLetters, 2010, 21 (09) : 1087 - 1090
  • [29] Design, synthesis and biological evaluation novel β-substituted indol-3-yl ethylamido melatoninergic analogues
    Iakovou, K
    Varvaresou, A
    Kourounakis, AP
    Stead, K
    Sugden, D
    Tsotinis, A
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (01) : 147 - 156
  • [30] Synthesis, Design and Anti-inflammatory Activity of Novel 5-(Indol-3-yl)thiazolidinone Derivatives as COX-2 Inhibitors
    Atta-Allah, Saad R.
    Ismail, Nasser S. M.
    Nassar, Ibrahim F.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (06) : 525 - 541